Abstract

Impaired gallbladder motility and delayed intestinal transit contribute to cholesterol gallstone formation by impeding the enterohepatic circulation of bile salts and causing gallbladder stasis. The therapeutic value of erythromycin, a prokinetic motilin analog, was evaluated in an animal model of gallstone formation. Eighty ground squirrels were fed either a trace- (control) or a high- (1%) cholesterol diet. Half of each diet group received either erythromycin stearate or placebo orally twice daily for 4 weeks. Biliary lipid secretion and bile salt pool size were determined via common duct cannulation. Gallbladder contractile response to cholecystokinin (CCK) was studied in vitro . Intestinal transit was evaluated in vivo by 51 Cr marker. In the placebo-treated group, fed the high- versus the trace-cholesterol diet, bile salt secretion decreased (trace-cholesterol + placebo, 21.0 ± 1.8 nmol/min/g liver vs. high-cholesterol + placebo, 9.3 ± 1.4 nmol/min/g liver), cholesterol saturation index (CSI) doubled (trace-cholesterol + placebo, 0.61 ± 0.06 vs. high-cholesterol + placebo, 1.30 ± 0.04), nucleation time shortened (trace-cholesterol + placebo, >21 days vs. high-cholesterol + placebo, 6.4 ± 1.0 days), cholesterol crystals formed, gallbladder contractility diminished, and intestinal transit was delayed (each P < .05). Erythromycin treatment of animals on the high-cholesterol diet restored gallbladder contractility and intestinal transit to control levels, increased bile salt secretion, reduced the total bile salt pool, lowered the cholesterol saturation of bile, lengthened the nucleation time, and so reduced crystal formation (each P < .05). Erythromycin enhances gallbladder motility and hastens intestinal transit, promoting more rapid enterohepatic cycling of bile salts. This increases bile salt secretion, improves cholesterol solubility, and reduces crystal development.

Keywords

ErythromycinInternal medicineMedicineGastroenterologyGround squirrelChemistryAntibioticsBiochemistry

MeSH Terms

AnimalsBileCholelithiasisCholesterolCholesterolDietaryDisease ModelsAnimalErythromycinGallbladderGastrointestinal MotilityLipid MetabolismMuscle ContractionSciuridae

Affiliated Institutions

Related Publications

Publication Info

Year
1998
Type
article
Volume
28
Issue
3
Pages
613-619
Citations
45
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

45
OpenAlex
2
Influential
27
CrossRef

Cite This

Qi-Wei Xu, Scott B. Patten, Daimen T. M. Tan et al. (1998). Effect of the prokinetic agent, erythromycin, in the richardson ground squirrel model of cholesterol gallstone disease. Hepatology , 28 (3) , 613-619. https://doi.org/10.1002/hep.510280302

Identifiers

DOI
10.1002/hep.510280302
PMID
9731548

Data Quality

Data completeness: 81%